This clinical-stage biotech advancing neurological therapies reported a notable insider sale as it progresses its drug pipeline.

SLS and TERN are advancing leukemia therapies, with TERN-701 targeting CML and GPS positioned as a Phase 3 maintenance ...

This ophthalmic biotech reported a notable insider sale as it advances treatments for Demodex blepharitis and other eye ...

Rocket Pharmaceuticals (RCKT) stock surged 9% after FDA approved KRESLADI, the first gene therapy for severe LAD-I in ...

Tarsus Pharmaceuticals sees its Relative Strength Rating move into the 80-plus level.

In this article, we will look at Jim Cramer’s breakdown of 16 stocks, including pharma plays for rising oil. The host of Mad ...

Large pharmaceutical companies, each with at least $20 billion in 2025 revenue, collectively reduced their workforces by more ...